July, 2022

'Flat is the new up': After biotech correction, venture investors turn to safer bets

Bio Pharma Dive

New companies are being built more carefully and platform technologies are less in vouge as the downturn's effects ripple through the private sector

284
284

Amazon’s big gamble

World of DTC Marketing

Quick Read: Amazon will dramatically expand its healthcare reach with its planned $3.9 billion acquisition of One Medical, a primary care provider with 188 offices in 25 markets nationwide but are they making a strategic move or a mistake?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin.

Personalizing the Cancer Patient Journey

Pharma Marketing Network

In the first two weeks after a cancer diagnosis, there are likely dozens of doctor’s visits, tests, consultations, and decision points.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Sky-High Prices Are Only Part of the Problem

NY Times

Inflation has unmasked the depths of our affordability crisis. United States Economy Prices (Fares, Fees and Rates) Drugs (Pharmaceuticals) Liberalism (US Politics) United States Politics and Government Center for Economic and Policy Research Republican Party Democratic Party

Drugs 84

Is FDA Going to Get A Little Help From Its Friends at the PTO?

FDA Law Blog

By Sara W. Koblitz — Drug pricing has been a hot button issue in the U.S. for decades, and patent protections have been cited as a source of “ gamesmanship ” allowing brand companies to keep drug prices high. Yet, as long as FDA and FTC have been trying to address anticompetitive behavior, the U.S.

More Trending

The fairytale of DTC TV ads

World of DTC Marketing

The pandemic is changing consumer behavior, and there is zero chance they will return to their carefree spending ways. Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales.

Is biotech facing a long bear market?

Pharmaceutical Technology

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence.

Addressing Rising Rx Costs

Pharmaceutical Commerce

How did the industry get here and what alternatives can be sought out?

83

Biden Administration Plans to Offer Updated Booster Shots in September

NY Times

With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.

Drugs 83

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Questions Frequently Asked Pertaining to Clinical Trials

Riverside Clinical Research

If you are considering playing a vital role in the advancement of medicine and medical technology by embarking on your first experience as a clinical trial volunteer, you most likely have a few questions about clinical research and the clinical trial process.

Moderna founder launches Apriori with $50M to stay ahead of virus variants

Bio Pharma Dive

Flagship Pioneering’s latest startup aims to use predictive technology to find “variant-proof” treatments and vaccines for infectious diseases before they might be needed

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes.

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Pharmaceutical Technology

According to GlobalData’s recent Niemann-Pick Type C (NPC): Opportunity Analysis and Forecast to 2031 report, the NPC market is expected to see significant growth during 2021–31.

Gene 98

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Thermo Fisher Scientific Declares Quarterly Dividend

BioTech 365

Thermo Fisher Scientific Declares Quarterly Dividend Thermo Fisher Scientific Declares Quarterly Dividend WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–Thermo Fisher Scientific Inc.

82

Omicron BA.5 Surge: 5 Ways to Stay Safe

NY Times

The BA.5 surge is a reminder that we need to take precautions to avoid illness, slow the relentless cycle of new variants and minimize the disruption to our daily lives.

Drugs 82

Fast and facile synthesis of antibacterial amino acid Schiff base copper complexes

Scienmag

Ever since their development in the late 19th century, Schiff bases have been a popular group of organic compounds, owing to their wide variety of desirable properties.

European regulator recommends Bavarian Nordic's vaccine for monkeypox

Bio Pharma Dive

The positive decision comes as governments aim to expand supply and quicken distribution of the vaccine to combat a widening global outbreak. Separately, the EMA backed approvals of 11 other medicines

The continued shame of pharma

World of DTC Marketing

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses.

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future.

Walgreens Boots Alliance Increases Quarterly Dividend

BioTech 365

Walgreens Boots Alliance Increases Quarterly Dividend Walgreens Boots Alliance Increases Quarterly Dividend DEERFIELD, Ill.–(BUSINESS –(BUSINESS WIRE)–Walgreens Boots Alliance, Inc.

81

F.D.A. to Weigh Over-the-Counter Sale of Birth Control Pills

NY Times

The first U.S. application for sale of a nonprescription birth control pill has taken on new meaning after the Supreme Court decision ending the constitutional right to abortion.

Sales 83

“Soft” CRISPR may offer a new fix for genetic defects

Scienmag

Curing debilitating genetic diseases is one of the great challenges of modern medicine.

De-risking oncology trials with medical monitoring

Bio Pharma Dive

Phase three oncology studies have approximately a 35% likelihood of leading to regulatory approval

Trials 274

Pharma’s platinum handcuffs

World of DTC Marketing

To address the “retention” problem, pharma companies are paying employees exorbitant salaries. The problem with that system is that people do whatever they need to to “hold onto” their high-paying jobs and become employees who are content not to excel.

GSK acquires US-based Sierra Oncology for $1.9bn

Pharmaceutical Technology

GlaxoSmithKline (GSK) has completed the acquisition of all outstanding shares of US-based Sierra Oncology in a deal totalling $1.9bn (£1.6bn), in cash. In April this year, GSK entered an agreement for the acquisition of Sierra Oncology for $55 per share.

AstraZeneca reports sales drop for Evusheld. Why is the variant-busting COVID med underachieving?

Fierce Pharma

AstraZeneca reports sales drop for Evusheld. Why is the variant-busting COVID med underachieving? kdunleavy. Fri, 07/29/2022 - 10:10

Sales 114

After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices

NY Times

Urgent questions arise about how care of pregnant women with cancer will change in states where women are unable to terminate pregnancies. Pregnancy and Childbirth Abortion Breast Cancer Cancer Drugs (Pharmaceuticals

Drugs 82

Safer web surfing with a new method for detecting malicious modes

Scienmag

With the ever-increasing importance of the Internet in our lives, there are growing attempts to exploit software vulnerabilities in our PCs for personal benefit. One way to do so is by infecting the victim’s PC with a malicious code injected through a website.

81

Versant partners with AbCellera to arm startups with better antibodies

Bio Pharma Dive

The companies pitch their collaboration as a way to give young drugmakers backed by Versant a head start. “Our business is advanced by great ideas coming into the funnel,” said AbCellera’s CEO

Are digital pharmacies the answer?

World of DTC Marketing

Digital pharmacies seem to be springing up everywhere. Allowing patients to order medications online and get delivery via Fed-Ex or the mail does offer time savings. Still, without a significant value (lower costs), they may not find an audience.

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine.

7 Most Common Types of Depression

Olympian Clinical Research

Depression is an illness that affects nearly 280 million people worldwide. There are several types of depression, each with its own set of symptoms and recommended treatment methods.

Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patients

NY Times

A new study found that sabizabulin reduced the risk of death by 55 percent, but some experts were cautious about overinterpreting the results. Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Clinical Trials Deaths (Fatalities) your-feed-healthcare sabizabulin

Drugs 82